FDA NDC Directory · JSON-LD · Markdown

MONJUVI

NDC 73535-208 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameTafasitamab-cxix
Labeler / ManufacturerIncyte Corporation
Marketing categoryBiologic License Application · App BLA761163
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTAFASITAMAB (200 mg/5mL)
Marketing started20200805
Package count1

External sources

Source: openFDA. Public-domain (CC0).